» Articles » PMID: 33305709

Myocardial Infarction with and Without ST-segment Elevation: a Contemporary Reappraisal of Similarities and Differences

Overview
Date 2020 Dec 11
PMID 33305709
Citations 31
Authors
Affiliations
Soon will be listed here.
Abstract

Understanding the similarities and differences between myocardial infarction with or without ST-segment elevation is an essential step for proper patients' management in current practice. Both syndromes are caused by critical stenosis or total occlusion of coronary arteries (mostly due to thrombosis on atherosclerotic plaque), and manifest with a similar clinical presentation. Recent epidemiologic studies show that the relative incidence of ST-segment elevation myocardial infarction (STEMI) and non-ST-segment elevation myocardial infarction (NSTEMI) moves in an opposite fashion (decreasing and increasing respectively), with a prognosis that is worse at short-term follow-up for STEMI but comparable at long-term. Current management differs, as for STEMIs, immediate reperfusion is recommended, while for NSTEMIs, risk stratification is mandatory in order to stratify patients' risk, and then decide the timing for coronary angiography. Periprocedural and technical aspects of the interventional management, as well as antithrombotic medications, are for the most similarly implemented in the two types of MI, with routine radial access, DES implant, and novel P2Y12 inhibitors representing the standard of care in both cases. The following review article aims to compare the two types of MI, with and without persistent STsegment elevation. The main purpose is to explore their similarities and differences and address areas of uncertainty with regards to clinical presentation, therapeutic management, and prognosis. The identification of high-risk NSTEMI patients is important as they may require an individualised approach that can substantially overlap with current STEMI recommendations, and their mortality remains high if their management is delayed.

Citing Articles

Cardiomyocytes in Hypoxia: Cellular Responses and Implications for Cell-Based Cardiac Regenerative Therapies.

Dwyer K, Snyder C, Coulombe K Bioengineering (Basel). 2025; 12(2).

PMID: 40001674 PMC: 11851968. DOI: 10.3390/bioengineering12020154.


Evaluation of Thrombomodulin, Heart-Type Fatty-Acid-Binding Protein, Pentraxin-3 and Galectin-3 Levels in Patients with Myocardial Infarction, with and Without ST Segment Elevation.

Misirlioglu N, Orucoglu G, Bicakhan B, Kucuk S, Himmetoglu S, Baykara Sayili S J Clin Med. 2025; 14(3).

PMID: 39941683 PMC: 11818096. DOI: 10.3390/jcm14031015.


Analyzing the non-linear relationship between fasting blood glucose levels and Gensini score in patients with STEMI.

Li H, Lin Q, Jiang Z, Zhong G Front Cardiovasc Med. 2025; 11:1427567.

PMID: 39749314 PMC: 11693739. DOI: 10.3389/fcvm.2024.1427567.


Mechanisms and Therapeutic Strategies for Myocardial Ischemia-Reperfusion Injury in Diabetic States.

Xue J, Zhuang J, Wang X, Meng T, Wu J, Zhang X ACS Pharmacol Transl Sci. 2024; 7(12):3691-3717.

PMID: 39698288 PMC: 11651189. DOI: 10.1021/acsptsci.4c00272.


Hemolytic anemia after percutaneous coronary intervention (PCI): A case report.

Zhang Y, Fuxiang A, Yan M, Zhou Y, Bian H Heliyon. 2024; 10(21):e39787.

PMID: 39524784 PMC: 11550028. DOI: 10.1016/j.heliyon.2024.e39787.


References
1.
Niccoli G, Burzotta F, Galiuto L, Crea F . Myocardial no-reflow in humans. J Am Coll Cardiol. 2009; 54(4):281-92. DOI: 10.1016/j.jacc.2009.03.054. View

2.
Goldberg R, Spencer F, Gore J, Lessard D, Yarzebski J . Thirty-year trends (1975 to 2005) in the magnitude of, management of, and hospital death rates associated with cardiogenic shock in patients with acute myocardial infarction: a population-based perspective. Circulation. 2009; 119(9):1211-9. PMC: 2730832. DOI: 10.1161/CIRCULATIONAHA.108.814947. View

3.
Lagerqvist B, Frobert O, Olivecrona G, Gudnason T, Maeng M, Alstrom P . Outcomes 1 year after thrombus aspiration for myocardial infarction. N Engl J Med. 2014; 371(12):1111-20. DOI: 10.1056/NEJMoa1405707. View

4.
Braunwald E . The open-artery theory is alive and well--again. N Engl J Med. 1993; 329(22):1650-2. DOI: 10.1056/NEJM199311253292211. View

5.
Widimsky P, Wijns W, Fajadet J, de Belder M, Knot J, Aaberge L . Reperfusion therapy for ST elevation acute myocardial infarction in Europe: description of the current situation in 30 countries. Eur Heart J. 2009; 31(8):943-57. PMC: 2854523. DOI: 10.1093/eurheartj/ehp492. View